loadpatents
Patent applications and USPTO patent grants for Grutter; Markus G..The latest application filed is for "use of prokaryotic sphingosine-1-phosphate lyases and of sphingosine-1-phosphate lyases lacking a transmembrane domain for treating hyperproliferative and other diseases".
Patent | Date |
---|---|
Use Of Prokaryotic Sphingosine-1-phosphate Lyases And Of Sphingosine-1-phosphate Lyases Lacking A Transmembrane Domain For Treating Hyperproliferative And Other Diseases App 20130259851 - Zangemeister-Wittke; Uwe ;   et al. | 2013-10-03 |
Process for the manufacture of thrombin inhibitors Grant 5,422,249 - Liersch , et al. June 6, 1 | 1995-06-06 |
DNA vector and recombinant host cell for production of hirullin P6 and P18 Grant 5,268,296 - Maschler , et al. December 7, 1 | 1993-12-07 |
Polypeptides with an anticoagulant activity Grant 5,114,922 - Maschler , et al. May 19, 1 | 1992-05-19 |
Hybrid interferons Grant 5,071,761 - Meyer , et al. December 10, 1 | 1991-12-10 |
Hybrid interferons Grant 4,885,166 - Meyer , et al. December 5, 1 | 1989-12-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.